BMC Cancer (Jan 2024)

microRNA-622 upregulates cell cycle process by targeting FOLR2 to promote CRC proliferation

  • Yuehong Chen,
  • Feng Liu,
  • Xinhua Chen,
  • Wenyi Li,
  • Kejun Li,
  • Hailang Cai,
  • Shunyi Wang,
  • Honglei Wang,
  • Ke Xu,
  • Chenxi Zhang,
  • Shengzhi Ye,
  • Yunhao Shen,
  • Tingyu Mou,
  • Shumin Cai,
  • Jianwei Zhou,
  • Jiang Yu

DOI
https://doi.org/10.1186/s12885-023-11766-6
Journal volume & issue
Vol. 24, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Background Epigenetic alterations contribute greatly to the development and progression of colorectal cancer, and effect of aberrant miR-622 expression is still controversial. This study aimed to discover miR-622 regulation in CRC proliferation. Methods miR-622 expression and prognosis were analyzed in clinical CRC samples from Nanfang Hospital. miR-622 regulation on cell cycle and tumor proliferation was discovered, and FOLR2 was screened as functional target of miR-622 using bioinformatics analysis, which was validated via dual luciferase assay and gain-of-function and loss-of-function experiments both in vitro and in vivo. Results miR-622 overexpression in CRC indicated unfavorable prognosis and it regulated cell cycle to promote tumor growth both in vitro and in vivo. FOLR2 is a specific, functional target of miR-622, which negatively correlates with signature genes in cell cycle process to promote CRC proliferation. Conclusions miR-622 upregulates cell cycle process by targeting FOLR2 to promote CRC proliferation, proposing a novel mechanism and treatment target in CRC epigenetic regulation of miR-622.

Keywords